ANAGENICS LIMITED - Announcements

0.00%

0.6¢

Market Cap $2.977M

Consumer Defensive Household & Personal Products

Anagenics Limited is an Australia-based health and beauty-tech company that operates... Anagenics Limited is an Australia-based health and beauty-tech company that operates health wellness and beauty business servicing wholesale and retail customers through omnichannel, offering premium branded products. The Company operates through its holding entity, Anagenics Limited and its main operating subsidiary company BLC Cosmetics Pty Limited (BLC) being a distributor of prestige beauty cosmetics and beauty equipment. BLC is an importer and distributor of prestige international and local skin care and wellbeing brands, namely Thalgo, Comfort Zone, Priori and other premium brands. BLC services over 1,000 spas, clinics, salons, retail stores and online in Australia, New Zealand and the Pacific Islands. The Company's brands consist of evolis and Uspa. Evolis is an anti-ageing hair care collection focused on harnessing the scientific research to give customers' thicker and healthier hair.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

AN1	Proposed issue of securities - CDY		16/09/21	27.81KB	Share
AN1	Cellmid to Acquire BLC Cosmetics Pty Ltd	PRICE SENSITIVE	16/09/21	135.96KB	Share
AN1	Appendix 4E and FY21 Financial Report	PRICE SENSITIVE	19/08/21	1.22MB	Share
AN1	Appendix 4C and Quarterly Activity Report	PRICE SENSITIVE	20/07/21	350.86KB	Share
AN1	Notification of cessation of securities - CDY		09/07/21	23.29KB	Share
AN1	MarketLit Investor Conference Presentation		02/07/21	1.57MB	Share
AN1	Cellmid Reports Record QVC Sales	PRICE SENSITIVE	17/06/21	182.91KB	Share
AN1	Release of Shares from Voluntary Escrow		11/06/21	122.36KB	Share
AN1	FGF5 Inhibitors Supply Agreement - Additional Information		10/06/21	103.47KB	Share
AN1	Supply Agreement for Cellmid's FGF5 Inhibitors	PRICE SENSITIVE	08/06/21	121.97KB	Share
AN1	Investor Briefing and Presentation		03/05/21	1.49MB	Share
AN1	Chinese Import Permits Received	PRICE SENSITIVE	30/04/21	108.95KB	Share
AN1	Investor Briefing		29/04/21	67.44KB	Share
AN1	Agreement Signed for Sale of Lyramid Limited	PRICE SENSITIVE	29/04/21	128.53KB	Share
AN1	Appendix 4C and Quarterly Activity Report	PRICE SENSITIVE	23/04/21	276.22KB	Share
AN1	Change of Director's Interest Notice - Eck		01/04/21	209.44KB	Share
AN1	Change of Director's Interest Notice - Cross		01/04/21	208.65KB	Share
AN1	Change of Director's Interest Notice - Halasz		01/04/21	212.24KB	Share
AN1	Change of Director's Interest Notice - Gordon		01/04/21	209.94KB	Share
AN1	CDYOA Top20 and Distribution List		01/04/21	150.21KB	Share
AN1	Appendix 2A		01/04/21	280.28KB	Share
AN1	Supplementary Prospectus	PRICE SENSITIVE	31/03/21	337.55KB	Share
AN1	Proposed issue of Securities - CDY		31/03/21	28.06KB	Share
AN1	Rights Issue Closed with Strong Demand	PRICE SENSITIVE	31/03/21	97.9KB	Share
AN1	Cellmid receives R&D tax credit		25/03/21	56.16KB	Share
AN1	Dispatch of Rights Issue Documentation Completed		12/03/21	82.54KB	Share
AN1	Investor Presentation		10/03/21	1.64MB	Share
AN1	Commencement of the Trading of Rights on the ASX		10/03/21	55.78KB	Share
AN1	Appendix 3B		08/03/21	740.74KB	Share
AN1	Rights Issue Prospectus	PRICE SENSITIVE	08/03/21	500.4KB	Share
AN1	Rights Issue	PRICE SENSITIVE	08/03/21	87.55KB	Share
AN1	Pause in Trading	PRICE SENSITIVE	08/03/21	115.08KB	Share
AN1	Appendix 4D and Half Year Report	PRICE SENSITIVE	18/02/21	894.7KB	Share
AN1	Cellmid Publishes Data on Novel Proprietary FGF5 Aptamer	PRICE SENSITIVE	09/02/21	79.99KB	Share
AN1	Appendix 4C and Quarterly Activity Report	PRICE SENSITIVE	25/01/21	379.06KB	Share
AN1	Cellmid Receives First Order From Chinese Distributor	PRICE SENSITIVE	25/01/21	59.56KB	Share
AN1	Appendix 2A		15/01/21	293.38KB	Share
AN1	Final Director's Interest Notice - King		04/01/21	153.42KB	Share
AN1	Change of Director's Interest Notice - Gordon		30/12/20	158.63KB	Share
AN1	Change of Director's Interest Notice - Halasz		30/12/20	207.49KB	Share
AN1	Change of Director's Interest Notice - King		30/12/20	159.73KB	Share
AN1	Confirming Changes to the Cellmid Board		24/12/20	58.39KB	Share
AN1	Newsletter		23/12/20	3.27MB	Share
AN1	Change of Director's Interest Notice - Eck		15/12/20	188.2KB	Share
AN1	Appendix 2A		15/12/20	293.63KB	Share
AN1	Cellmid Signs 10 Year Chinese Distribution Agreement	PRICE SENSITIVE	14/12/20	75.78KB	Share
AN1	Initial Director's Interest Notice - Eck-Thompson		03/12/20	153.53KB	Share
AN1	Final Director's Interest Notice - Walton		03/12/20	153.32KB	Share
AN1	Results of Meeting		30/11/20	75.11KB	Share
AN1	AGM Presentation to Shareholders		30/11/20	1.45MB	Share
AN1	Annual General Meeting - Change of Agenda		30/11/20	58.36KB	Share
AN1	Annual General Meeting Update		23/11/20	80KB	Share
AN1	Growth Strategy Presentation	PRICE SENSITIVE	12/11/20	1.65MB	Share
AN1	Release of Shares from Voluntary Escrow		05/11/20	56.26KB	Share
AN1	Letter to Shareholders - Notice of Annual General Meeting		30/10/20	1.19MB	Share
AN1	Notice of Annual General Meeting/Proxy Form		30/10/20	1.55MB	Share
AN1	Appendix 4C and Quarterly Activity Report	PRICE SENSITIVE	22/10/20	279.51KB	Share
AN1	Board Renewal To Align With Consumer Health Growth Strategy		21/10/20	69.65KB	Share
AN1	Date of Annual General Meeting		12/10/20	58.57KB	Share
AN1	Section 249D Notice		07/10/20	68.87KB	Share
AN1	Appendix 4G and Corporate Governance Statement		15/09/20	420.35KB	Share
AN1	Annual Report to shareholders		15/09/20	2.29MB	Share
AN1	CDY Engages Advisers to Facilitate Divestment from Lyramid		10/09/20	71.18KB	Share
AN1	FY20 Results Presentation		27/08/20	1.82MB	Share
AN1	FY20 Financial Results	PRICE SENSITIVE	27/08/20	73.95KB	Share
AN1	Appendix 4E and FY20 Financial Report	PRICE SENSITIVE	27/08/20	1.34MB	Share
AN1	CDY Signs Agreement With Premium Salon Distributor in USA	PRICE SENSITIVE	28/07/20	75.8KB	Share
AN1	Appendix 4C and Quarterly Activity Report	PRICE SENSITIVE	22/07/20	391.46KB	Share
AN1	Response to ASX Aware Query	PRICE SENSITIVE	09/07/20	218.16KB	Share
AN1	Cellmid Signs Exclusive Agreement For Sars-Cov-2 Laboratory	PRICE SENSITIVE	09/07/20	102.44KB	Share
AN1	Trading Halt	PRICE SENSITIVE	07/07/20	189.6KB	Share
AN1	Pause in Trading	PRICE SENSITIVE	07/07/20	113.64KB	Share
AN1	Extension Of Wondfo Rapid Test Distribution Agreement	PRICE SENSITIVE	02/07/20	84.81KB	Share
AN1	Change of Director's Interest Notice - Halasz		23/06/20	245.13KB	Share
AN1	Change in substantial holding		18/06/20	652.23KB	Share
AN1	Change of Director's Interest Notice - Eck		18/06/20	158.59KB	Share
AN1	Change of Director's Interest Notice - Halasz		18/06/20	207.02KB	Share
AN1	Appendix 3G		18/06/20	277.59KB	Share
AN1	Appendix 2A		18/06/20	274.51KB	Share
AN1	Cellmid Reports on Strong QVC Sales Event	PRICE SENSITIVE	16/06/20	74.79KB	Share
AN1	Reinstatement to Official Quotation	PRICE SENSITIVE	15/06/20	86.79KB	Share
AN1	Cellmid Reports on Results of The Doherty Institute Testing	PRICE SENSITIVE	15/06/20	147.69KB	Share
AN1	CDY signs Introducer Agreement to broaden product offering	PRICE SENSITIVE	04/06/20	161.98KB	Share
AN1	Appointment of Dr Dominic Burg as Chief Operating Officer	PRICE SENSITIVE	01/06/20	65.5KB	Share
AN1	Results of Meeting		21/05/20	99.49KB	Share
AN1	General Meeting Presentation		21/05/20	1.93MB	Share
AN1	Company Update		15/05/20	83.31KB	Share
AN1	Update on General Meeting		14/05/20	1.78MB	Share
AN1	Suspension from Official Quotation	PRICE SENSITIVE	11/05/20	167.03KB	Share
AN1	Trading Halt	PRICE SENSITIVE	07/05/20	171.11KB	Share
AN1	Pause in Trading	PRICE SENSITIVE	07/05/20	114.21KB	Share
AN1	Appendix 2A		04/05/20	270.52KB	Share
AN1	Cellmid Share Purchase Plan Completed		01/05/20	57.63KB	Share
AN1	Appendix 4C and Quarterly Activity Report	PRICE SENSITIVE	27/04/20	264.22KB	Share
AN1	Cellmid's Alopecia Patent Allowed in Australia and Japan	PRICE SENSITIVE	24/04/20	137.08KB	Share
AN1	Independent Test Results For The Wondfo SARS-CoV-2 Test	PRICE SENSITIVE	22/04/20	77.02KB	Share
AN1	Notice of General Meeting/Proxy Form		21/04/20	1.58MB	Share
AN1	Security Purchase Plan		17/04/20	212.38KB	Share
AN1	Cellmid's Shipment of SARS-CoV-2 Tests Received	PRICE SENSITIVE	14/04/20	61.63KB	Share
AN1	Pause in Trading	PRICE SENSITIVE	14/04/20	114.6KB	Share

AN1 Proposed issue of securities - CDY
16/09/21		27.81KB	Share
AN1 Cellmid to Acquire BLC Cosmetics Pty Ltd
16/09/21	PRICE SENSITIVE	135.96KB	Share
AN1 Appendix 4E and FY21 Financial Report
19/08/21	PRICE SENSITIVE	1.22MB	Share
AN1 Appendix 4C and Quarterly Activity Report
20/07/21	PRICE SENSITIVE	350.86KB	Share
AN1 Notification of cessation of securities - CDY
09/07/21		23.29KB	Share
AN1 MarketLit Investor Conference Presentation
02/07/21		1.57MB	Share
AN1 Cellmid Reports Record QVC Sales
17/06/21	PRICE SENSITIVE	182.91KB	Share
AN1 Release of Shares from Voluntary Escrow
11/06/21		122.36KB	Share
AN1 FGF5 Inhibitors Supply Agreement - Additional Information
10/06/21		103.47KB	Share
AN1 Supply Agreement for Cellmid's FGF5 Inhibitors
08/06/21	PRICE SENSITIVE	121.97KB	Share
AN1 Investor Briefing and Presentation
03/05/21		1.49MB	Share
AN1 Chinese Import Permits Received
30/04/21	PRICE SENSITIVE	108.95KB	Share
AN1 Investor Briefing
29/04/21		67.44KB	Share
AN1 Agreement Signed for Sale of Lyramid Limited
29/04/21	PRICE SENSITIVE	128.53KB	Share
AN1 Appendix 4C and Quarterly Activity Report
23/04/21	PRICE SENSITIVE	276.22KB	Share
AN1 Change of Director's Interest Notice - Eck
01/04/21		209.44KB	Share
AN1 Change of Director's Interest Notice - Cross
01/04/21		208.65KB	Share
AN1 Change of Director's Interest Notice - Halasz
01/04/21		212.24KB	Share
AN1 Change of Director's Interest Notice - Gordon
01/04/21		209.94KB	Share
AN1 CDYOA Top20 and Distribution List
01/04/21		150.21KB	Share
AN1 Appendix 2A
01/04/21		280.28KB	Share
AN1 Supplementary Prospectus
31/03/21	PRICE SENSITIVE	337.55KB	Share
AN1 Proposed issue of Securities - CDY
31/03/21		28.06KB	Share
AN1 Rights Issue Closed with Strong Demand
31/03/21	PRICE SENSITIVE	97.9KB	Share
AN1 Cellmid receives R&D tax credit
25/03/21		56.16KB	Share
AN1 Dispatch of Rights Issue Documentation Completed
12/03/21		82.54KB	Share
AN1 Investor Presentation
10/03/21		1.64MB	Share
AN1 Commencement of the Trading of Rights on the ASX
10/03/21		55.78KB	Share
AN1 Appendix 3B
08/03/21		740.74KB	Share
AN1 Rights Issue Prospectus
08/03/21	PRICE SENSITIVE	500.4KB	Share
AN1 Rights Issue
08/03/21	PRICE SENSITIVE	87.55KB	Share
AN1 Pause in Trading
08/03/21	PRICE SENSITIVE	115.08KB	Share
AN1 Appendix 4D and Half Year Report
18/02/21	PRICE SENSITIVE	894.7KB	Share
AN1 Cellmid Publishes Data on Novel Proprietary FGF5 Aptamer
09/02/21	PRICE SENSITIVE	79.99KB	Share
AN1 Appendix 4C and Quarterly Activity Report
25/01/21	PRICE SENSITIVE	379.06KB	Share
AN1 Cellmid Receives First Order From Chinese Distributor
25/01/21	PRICE SENSITIVE	59.56KB	Share
AN1 Appendix 2A
15/01/21		293.38KB	Share
AN1 Final Director's Interest Notice - King
04/01/21		153.42KB	Share
AN1 Change of Director's Interest Notice - Gordon
30/12/20		158.63KB	Share
AN1 Change of Director's Interest Notice - Halasz
30/12/20		207.49KB	Share
AN1 Change of Director's Interest Notice - King
30/12/20		159.73KB	Share
AN1 Confirming Changes to the Cellmid Board
24/12/20		58.39KB	Share
AN1 Newsletter
23/12/20		3.27MB	Share
AN1 Change of Director's Interest Notice - Eck
15/12/20		188.2KB	Share
AN1 Appendix 2A
15/12/20		293.63KB	Share
AN1 Cellmid Signs 10 Year Chinese Distribution Agreement
14/12/20	PRICE SENSITIVE	75.78KB	Share
AN1 Initial Director's Interest Notice - Eck-Thompson
03/12/20		153.53KB	Share
AN1 Final Director's Interest Notice - Walton
03/12/20		153.32KB	Share
AN1 Results of Meeting
30/11/20		75.11KB	Share
AN1 AGM Presentation to Shareholders
30/11/20		1.45MB	Share
AN1 Annual General Meeting - Change of Agenda
30/11/20		58.36KB	Share
AN1 Annual General Meeting Update
23/11/20		80KB	Share
AN1 Growth Strategy Presentation
12/11/20	PRICE SENSITIVE	1.65MB	Share
AN1 Release of Shares from Voluntary Escrow
05/11/20		56.26KB	Share
AN1 Letter to Shareholders - Notice of Annual General Meeting
30/10/20		1.19MB	Share
AN1 Notice of Annual General Meeting/Proxy Form
30/10/20		1.55MB	Share
AN1 Appendix 4C and Quarterly Activity Report
22/10/20	PRICE SENSITIVE	279.51KB	Share
AN1 Board Renewal To Align With Consumer Health Growth Strategy
21/10/20		69.65KB	Share
AN1 Date of Annual General Meeting
12/10/20		58.57KB	Share
AN1 Section 249D Notice
07/10/20		68.87KB	Share
AN1 Appendix 4G and Corporate Governance Statement
15/09/20		420.35KB	Share
AN1 Annual Report to shareholders
15/09/20		2.29MB	Share
AN1 CDY Engages Advisers to Facilitate Divestment from Lyramid
10/09/20		71.18KB	Share
AN1 FY20 Results Presentation
27/08/20		1.82MB	Share
AN1 FY20 Financial Results
27/08/20	PRICE SENSITIVE	73.95KB	Share
AN1 Appendix 4E and FY20 Financial Report
27/08/20	PRICE SENSITIVE	1.34MB	Share
AN1 CDY Signs Agreement With Premium Salon Distributor in USA
28/07/20	PRICE SENSITIVE	75.8KB	Share
AN1 Appendix 4C and Quarterly Activity Report
22/07/20	PRICE SENSITIVE	391.46KB	Share
AN1 Response to ASX Aware Query
09/07/20	PRICE SENSITIVE	218.16KB	Share
AN1 Cellmid Signs Exclusive Agreement For Sars-Cov-2 Laboratory
09/07/20	PRICE SENSITIVE	102.44KB	Share
AN1 Trading Halt
07/07/20	PRICE SENSITIVE	189.6KB	Share
AN1 Pause in Trading
07/07/20	PRICE SENSITIVE	113.64KB	Share
AN1 Extension Of Wondfo Rapid Test Distribution Agreement
02/07/20	PRICE SENSITIVE	84.81KB	Share
AN1 Change of Director's Interest Notice - Halasz
23/06/20		245.13KB	Share
AN1 Change in substantial holding
18/06/20		652.23KB	Share
AN1 Change of Director's Interest Notice - Eck
18/06/20		158.59KB	Share
AN1 Change of Director's Interest Notice - Halasz
18/06/20		207.02KB	Share
AN1 Appendix 3G
18/06/20		277.59KB	Share
AN1 Appendix 2A
18/06/20		274.51KB	Share
AN1 Cellmid Reports on Strong QVC Sales Event
16/06/20	PRICE SENSITIVE	74.79KB	Share
AN1 Reinstatement to Official Quotation
15/06/20	PRICE SENSITIVE	86.79KB	Share
AN1 Cellmid Reports on Results of The Doherty Institute Testing
15/06/20	PRICE SENSITIVE	147.69KB	Share
AN1 CDY signs Introducer Agreement to broaden product offering
04/06/20	PRICE SENSITIVE	161.98KB	Share
AN1 Appointment of Dr Dominic Burg as Chief Operating Officer
01/06/20	PRICE SENSITIVE	65.5KB	Share
AN1 Results of Meeting
21/05/20		99.49KB	Share
AN1 General Meeting Presentation
21/05/20		1.93MB	Share
AN1 Company Update
15/05/20		83.31KB	Share
AN1 Update on General Meeting
14/05/20		1.78MB	Share
AN1 Suspension from Official Quotation
11/05/20	PRICE SENSITIVE	167.03KB	Share
AN1 Trading Halt
07/05/20	PRICE SENSITIVE	171.11KB	Share
AN1 Pause in Trading
07/05/20	PRICE SENSITIVE	114.21KB	Share
AN1 Appendix 2A
04/05/20		270.52KB	Share
AN1 Cellmid Share Purchase Plan Completed
01/05/20		57.63KB	Share
AN1 Appendix 4C and Quarterly Activity Report
27/04/20	PRICE SENSITIVE	264.22KB	Share
AN1 Cellmid's Alopecia Patent Allowed in Australia and Japan
24/04/20	PRICE SENSITIVE	137.08KB	Share
AN1 Independent Test Results For The Wondfo SARS-CoV-2 Test
22/04/20	PRICE SENSITIVE	77.02KB	Share
AN1 Notice of General Meeting/Proxy Form
21/04/20		1.58MB	Share
AN1 Security Purchase Plan
17/04/20		212.38KB	Share
AN1 Cellmid's Shipment of SARS-CoV-2 Tests Received
14/04/20	PRICE SENSITIVE	61.63KB	Share
AN1 Pause in Trading
14/04/20	PRICE SENSITIVE	114.6KB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 0.6¢		Change 0.000(0.00%)		Mkt cap ! $2.977M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
2	1380288	0.6¢

Sellers (Offers)

Price($)	Vol.	No.
0.7¢	71510	1

View Market Depth

No.	Vol.	Price($)
2	1380288	0.006
1	750000	0.005
6	7665000	0.004
3	5450000	0.003
1	800000	0.002

Price($)	Vol.	No.
0.007	71510	1
0.008	653713	2
0.009	728000	3
0.010	500000	1
0.015	200000	1

Last trade - 16.21pm 13/08/2025 (20 minute delay)

AN1 (ASX) Chart

Day chart unavailable

ANAGENICS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available